Diamicron MR 60mg

Product Information *

  • Company:

    Servier Laboratories Ireland Ltd
  • Status:

    No Recent Update
  • Active Ingredients * :

    *Additional information is available upon request

  • Legal Category:

    Product subject to medical prescription which may be renewed (B)

When a pharmaceutical company changes any document, a new version is published on medicines.ie. For each version, we show the dates it was published on medicines.ie and the reasons for change.

Updated on 02 April 2020

Reasons for updating

  • Change to section 2 - what you need to know - contraindications
  • Change to section 4 - possible side effects
  • Change to section 6 - what the product looks like and pack contents

Updated on 19 March 2020

Reasons for updating

  • Change to section 4.4 - Special warnings and precautions for use
  • Change to section 4.8 - Undesirable effects
  • Change to section 6.5 - Nature and contents of container
  • Change to section 10 - Date of revision of the text

Legal category:Product subject to medical prescription which may be renewed (B)

Updated on 31 May 2016

Reasons for updating

  • Change to section 4.4 - Special warnings and precautions for use
  • Change to section 4.5 - Interaction with other medicinal products and other forms of interaction

Free text change information supplied by the pharmaceutical company

  Correction of sulphonylurea by sulfonylurea in sections 4.2, 4.3, 4.8, 5.1.

  Addition of St. John's Wort (Hypericum perforatum) preparations in sections 4.4 and 4.5 as products that may cause an increase in blood glucose levels.

  Addition of dysglycaemia section in 4.4.

  Addition of fluroniquinolones in section 4.5 as products that may cause dysglycaemia.

Updated on 31 May 2016

Reasons for updating

  • Change to section 4.4 - Special warnings and precautions for use
  • Change to section 4.5 - Interaction with other medicinal products and other forms of interaction

Legal category:Product subject to medical prescription which may be renewed (B)

Free text change information supplied by the pharmaceutical company

  Correction of sulphonylurea by sulfonylurea in sections 4.2, 4.3, 4.8, 5.1.

  Addition of St. John's Wort (Hypericum perforatum) preparations in sections 4.4 and 4.5 as products that may cause an increase in blood glucose levels.

  Addition of dysglycaemia section in 4.4.

  Addition of fluroniquinolones in section 4.5 as products that may cause dysglycaemia.

Updated on 31 May 2016

Reasons for updating

  • New PIL for new product

Updated on 31 May 2016

Reasons for updating

  • New SPC for new product

Legal category:Product subject to medical prescription which may be renewed (B)

Updated on 17 June 2015

Reasons for updating

  • Change to section 9 - Date of renewal of authorisation

Free text change information supplied by the pharmaceutical company

Date of Renewal of Authorisation: 20th May 2015

Updated on 17 June 2015

Reasons for updating

  • Change to section 9 - Date of renewal of authorisation

Legal category:Product subject to medical prescription which may be renewed (B)

Free text change information supplied by the pharmaceutical company

Date of Renewal of Authorisation: 20th May 2015

Updated on 09 October 2012

Reasons for updating

  • New SPC for medicines.ie

Free text change information supplied by the pharmaceutical company

None provided

Updated on 09 October 2012

Reasons for updating

  • New SPC for medicines.ie

Legal category:Product subject to medical prescription which may be renewed (B)

Free text change information supplied by the pharmaceutical company

None provided